$DK

FINNERTY WILLIAM J sold $258K of DK

FINNERTY WILLIAM J sold 5,000 shares of Delek US Holdings, Inc. (DK) at $51.50 ($0.26M total) on 2026-06-29 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · FINNERTY WILLIAM J
Published Jul 2, 2026, 12:47 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 2, 2026, 1:01 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$DK
Neutral
high confidence
Mentioned
$DK
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$DKNeutralLow
01

Why it matters

The disclosure updates insider activity records but does not introduce new operational, financial, or regulatory information.

02

Market read

Traders may note insider selling, but the 10b5-1 structure makes it less actionable as a directional catalyst.

03

What to watch

The article does not disclose any concurrent purchases, changes in role, or new company fundamentals—so the trading signal is mostly sentiment/positioning rather than fundamentals.

Relevance 3/10Novelty 3/10Timing: New Form 4 filed 2026-07-01 for a 2026-06-29 sale.

Background

SEC Form 4 insider transaction for Delek US Holdings, Inc. (DK) by a director.

Company-level read

Ticker impact

$DKNeutralHigh confidence
Context

Delek US Holdings director FINNERTY WILLIAM J sold 5,000 shares at $51.50 on 2026-06-29 under a 10b5-1 plan, per Form 4.

Expected impact

Low likelihood of a sustained price move; any reaction is likely muted and short-lived.

Evidence & confidence

The filing is a Form 4 open-market sale with an explicitly pre-arranged 10b5-1 plan, which typically reduces interpretive value versus discretionary selling.

Market effects

No sector read-through; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations.

Key entities

  • Delek US Holdings, Inc.

    Subject of the Form 4 insider transaction; director sold shares under a 10b5-1 plan.

  • FINNERTY WILLIAM J

    Director who executed an open-market sale of 5,000 shares at $51.50 on 2026-06-29.

Related articles

$DKMed

Delek US Q2 Earnings Call Highlights

Delek US (NYSE: DK) Q2 earnings call covered refining margins, throughput guidance, and cash flow. Management said refined-product markets may take several quarters to normalize and that a less backwardated forward curve could lift realized crack spreads. Q3 throughput guided to 296,000-316,000 bpd, with Opex $220-$230M and D&A $110-$120M. Delek Logistics Partners reported ~$144M adjusted EBITDA and reaffirmed 2026 guidance of $520-$560M.

$DKMedAI 8/10

Delek US Holdings (DK) Q2 2026 Earnings Call Transcript

Delek US Holdings (DK) reported Q2 2026 net income of $170 million ($2.71/share) and adjusted net income of $344 million ($5.48/share). Adjusted EBITDA was $639 million, with RVO-adjusted EBITDA of $490 million and RVO-adjusted EPS of $3.64. Logistics segment adjusted EBITDA was a record $144 million. DKL full-year 2026 EBITDA guidance is $520 million to $560 million.

$DKMed

Delek Slides on Q2 Results

Delek US Holdings (NYSE: DK) reported Q2 ended June 30, 2026 net income of $169.5M ($2.71/share) and adjusted net income of $343.9M ($5.48/share). Adjusted EBITDA was $638.7M; excluding RVO impacts, adjusted EPS was $3.64 and adjusted EBITDA $490.1M. Delek Logistics posted adjusted EBITDA of $143.5M and is targeting $520-560M. Delek bought $20M of DK shares and paid $15.6M in dividends, declaring a $0.255 quarterly dividend.

$DKMedAI 8/10

This is Why Delek US Holdings, Inc. (DK) is One of the Best Oil Stocks to Buy Amid US-Iran War

Delek US Holdings (NYSE:DK) said on April 29 it is improving cash flow via its Enterprise Optimization Plan. In Q1, it completed the Big Spring refinery turnaround on time and on budget and continued ramp-up of the Delaware basin Libby 2 sour gas plant. Adjusted net income was $4.7M ($0.08/share) and adjusted EBITDA $211.7M. Revenue was $2.65B vs $2.42B expected; it ended with $624.1M cash and $3.18B long-term debt.